合成路线1
该中间体在本合成路线中的序号:
(IV) When 4-phenyl-3-oxobutanoic acid methyl ester (I) were reacted with thiourea (II), in the presence of sodium methoxide, condensation occurred with formation of 3,4-dihydro-6-benzyl-4-oxo-2-thioxopyrimidine (III). Reaction of the compound (III) with sec-butyl chloride (IV) in alkaline medium afforded the required 2-(sec-butylthio)-6-benzyl-3,4-dihydro-4-oxopyrimidine
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21791 |
4-chloro-2-[(1-methyl-4-piperidinyl)sulfanyl]phenylamine; 4-chloro-2-[(1-methyl-4-piperidinyl)sulfanyl]aniline
|
|
C12H17ClN2S |
详情 |
详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
51793 |
6-benzyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C11H10N2OS |
详情 |
详情
|
(IV) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) When 4-(3-methylphenyl-3-oxobutanoic acid methyl ester (I) were reacted with thiourea (II), in the presence of sodium methoxide, condensation occurred with formation of 3,4-dihydro-6-(3-methylbenzyl)-4-oxo-2-thioxopyrimidine (III). Reaction of the compound (III) with sec-butyl chloride (IV) in alkaline medium afforded the required 2-(sec-butylthio)-6-(3-methylbenzyl)-3,4-dihydro-4-oxopyrimidine
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51787 |
methyl (Z)-3-hydroxy-4-(3-methylphenyl)-2-butenoate
|
|
C12H14O3 |
详情 |
详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
51801 |
6-(3-methylbenzyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C12H12N2OS |
详情 |
详情
|
(IV) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(IV) When 2-methyl-4-phenyl-3-oxobutanoic acid methyl ester (I) were reacted with thiourea (II), in the presence of sodium methoxide, condensation occurred with formation of 5-methyl-3,4-dihydro-6-benzyl-4-oxo-2-thioxopyrimidine (III). Reaction of compound (III) with sec-butyl chloride (IV) in alkaline medium afforded the required 2-(sec-butylthio)-5-methyl-6-benzyl-3,4-dihydro-4-oxopyrimidine
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51789 |
methyl (Z)-3-hydroxy-2-methyl-4-phenyl-2-butenoate
|
|
C12H14O3 |
详情 |
详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
51800 |
6-benzyl-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C12H12N2OS |
详情 |
详情
|
(IV) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(IV) When 2-methyl-4-(3-methylphenyl)-3-oxobutanoic acid methyl ester (I) were reacted with thiourea (II), in the presence of sodium methoxide, condensation occurred with formation of 5-methyl-3,4-dihydro-6-(3-methylbenzyl)-4-oxo-2-thioxopyrimidine (III). Reaction of compound (III) with sec-butyl chloride (IV) in alkaline medium afforded the required 2-(sec-butylthio)-5-methyl-6-(3-methylbenzyl)-3,4-dihydro-4-oxopyrimidine
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51785 |
methyl (Z)-3-hydroxy-2-methyl-4-(3-methylphenyl)-2-butenoate
|
|
C13H16O3 |
详情 |
详情
|
(II) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(III) |
51799 |
5-methyl-6-(3-methylbenzyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C13H14N2OS |
详情 |
详情
|
(IV) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) The condensation of 2-(2,6-difluorophenyl)acetic acid (I) with lmalonic acid monoethyl ester sodium salt (II) gives 4-(2,6-difluorophenyl)-3-oxobutyric acid ethyl ester (III), which is cyclized with thiourea (IV) to yield 6-(2,6-difluorobenzyl)-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (V). Finally this compound is reacted with 1-ethylpropyl chloride (VI) by means of K2CO3 to afford the target pyrimidinone.
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51809 |
2,6-Difluorophenylacetic acid
|
85068-28-6 |
C8H6F2O2 |
详情 | 详情
|
(II) |
14338 |
potassium 3-ethoxy-3-oxopropanoate
|
6148-64-7 |
C5H7KO4 |
详情 | 详情
|
(III) |
51810 |
ethyl 4-(2,6-difluorophenyl)-3-oxobutanoate
|
|
C12H12F2O3 |
详情 |
详情
|
(IV) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(V) |
51811 |
6-(2,6-difluorobenzyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C11H8F2N2OS |
详情 |
详情
|
(VI) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(VI) The condensation of 2-(2,6-difluorophenyl)acetic acid (I) with 2-methyllmalonic acid monoethyl ester sodium salt (II) gives 4-(2,6-difluorophenyl)-2-methyl-3-oxobutyric acid ethyl ester (III), which is cyclized with thiourea (IV) to yield 6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (V). Finally this compound is reacted with 1-ethylpropyl chloride (VI) by means of K2CO3 to afford the target pyrimidinone.
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51809 |
2,6-Difluorophenylacetic acid
|
85068-28-6 |
C8H6F2O2 |
详情 | 详情
|
(II) |
51813 |
potassium 3-ethoxy-2-methyl-3-oxopropanoate
|
|
C6H9KO4 |
详情 |
详情
|
(III) |
51814 |
ethyl 4-(2,6-difluorophenyl)-2-methyl-3-oxobutanoate
|
|
C13H14F2O3 |
详情 |
详情
|
(IV) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(V) |
51815 |
6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C12H10F2N2OS |
详情 |
详情
|
(VI) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(VI) The condensation of 2-(2,6-difluorophenyl)acetic acid (I) with 2-ethyllmalonic acid monoethyl ester sodium salt (II) gives 4-(2,6-difluorophenyl)--2-ethyl-3-oxobutyric acid ethyl ester (III), which is cyclized with thiourea (IV) to yield 6-(2,6-difluorobenzyl)-5-ethyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (V). Finally this compound is reacted with 1-ethylpropyl chloride (VI) by means of K2CO3 to afford the target pyrimidinone.
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51809 |
2,6-Difluorophenylacetic acid
|
85068-28-6 |
C8H6F2O2 |
详情 | 详情
|
(II) |
51812 |
potassium 2-(ethoxycarbonyl)butanoate
|
|
C7H11KO4 |
详情 |
详情
|
(III) |
51816 |
ethyl 4-(2,6-difluorophenyl)-2-ethyl-3-oxobutanoate
|
|
C14H16F2O3 |
详情 |
详情
|
(IV) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(V) |
51817 |
6-(2,6-difluorobenzyl)-5-ethyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C13H12F2N2OS |
详情 |
详情
|
(VI) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The alkylation of 6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (I) with 1-methylpropyl chloride (II) by means of K2CO3 gives 6-(2,6-difluorobenzyl)-5-methyl-2-(1-methylpropylsulfanyl)pyridmidin-4(3H)-one (III), which is then methylated with Me-Cl and LDA in THF/HMPA to yield the target alpha-methylbenzyl pyrimidinone.
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51815 |
6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C12H10F2N2OS |
详情 |
详情
|
(II) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|
(III) |
51824 |
2-(sec-butylsulfanyl)-6-(2,6-difluorobenzyl)-5-methyl-4(3H)-pyrimidinone
|
|
C16H18F2N2OS |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VII) The methylation of 2-(2,6-difluorophenyl)acetic acid (I) with Me-Cl and LDA in THF/HMPA gives 2-(2,6-difluorophenyl)propionic acid (II), which is condensed with 2-methylmalonic acid monoethyl ester potassium salt (III) to yield 4-(2,6-difluorophenyl)-2-methyl-3-oxopentanoic acid (IV). The cyclization of (IV) with thiourea (V) affords 6-[1-(2,6-difluorophenyl)ethyl]-5-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (VI), which is finally alkylated with 1-methylpropyl chloride (VII) to provide the target pyrimidinone derivative.
【1】
Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51809 |
2,6-Difluorophenylacetic acid
|
85068-28-6 |
C8H6F2O2 |
详情 | 详情
|
(II) |
51820 |
2-(2,6-difluorophenyl)propionic acid
|
|
C9H8F2O2 |
详情 |
详情
|
(III) |
51813 |
potassium 3-ethoxy-2-methyl-3-oxopropanoate
|
|
C6H9KO4 |
详情 |
详情
|
(IV) |
51821 |
ethyl 4-(2,6-difluorophenyl)-2-methyl-3-oxopentanoate
|
|
C14H16F2O3 |
详情 |
详情
|
(V) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(VI) |
51822 |
6-[1-(2,6-difluorophenyl)ethyl]-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone
|
|
C13H12F2N2OS |
详情 |
详情
|
(VII) |
51797 |
1-methylpropyl chloride; 2-Chlorobutane; 1-Chloro-1-methylpropane; Sec-Butyl Chloride
|
78-86-4 |
C4H9Cl |
详情 | 详情
|